Effects of lecithin: Cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels

Journal of Clinical Lipidology

Volumn 5, Issue 3, 2011, Pages 152-158

  Agirbasli, Deniz ^a,b   Cirakoglu, Beyazit ^b   Eren, Fatih ^a   Sumerkan, Mutlu ^a   Aksoy, Sukru ^c   Aral, Cenk ^a   Agirbasli, Mehmet ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b ACIBADEM UNIVERSITY   (Turkey)

^c DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Coronary artery disease; Enzyme activity; Enzyme level; Genetic polymorphisms; High density lipoprotein cholesterol; Lecithin:cholesterol acyltransferase

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRIACYLGLYCEROL;

ANTHROPOMETRY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; COLORIMETRY; CONFERENCE PAPER; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES; TURKEY;

EID: 79956287691     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.02.008     Document Type: Conference Paper

References (35)

1. P.J. Barter, M. Caulfield, M. Eriksson ILLUMINATE investigators Effects of torcetrapib in patients at high risk for coronary events N Engl J Med 357 2007 2109 2122 (Pubitemid 350146106)
2. G. Franceschini, C.R. Sirtori, A. Capurso, K.H. Weisgraber, and R.W. Mahley A-I Milano apoprotein: decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family J Clin Invest 66 1980 892 900 (Pubitemid 11233787)
3. E.M. deGoma, R.L. deGoma, and D.J. Rader Beyond high-density lipoprotein cholesterol levels: evaluating high-density lipoprotein function as influenced by novel therapeutic approaches J Am Coll Cardiol 51 2008 2199 2211 (Pubitemid 351754991)
4. R.W. Mahley, K.E. Paloglu, and Z. Atak Turkish Heart Study: lipids, lipoproteins, and apolipoproteins J Lipid Res 36 1995 839 859
5. A. Onat, M.A. Büyükbese, E. Ural, Kele, D. Ural, and E. nce HDL-cholesterol and fibrinogen levels and associations with some risk factors in the population of the Marmara region Arch Turk Soc Cardiol 25 1997 520 525
6. M. Agirbasli, G. Ciliv, S. Cakir, S. Srinivasan, G.S. Berenson, and S. Ozme Body mass index and lipid levels in children from Ankara, Turkey versus Bogalusa, Louisiana Prev Med 41 2005 843 845 (Pubitemid 41772661)
7. M. Porsch-Oezcueruemez, Y. Bilgin, and M. Wollny Prevalence of risk factors of coronary heart disease in Turks living in Germany: The Giessen Study Atherosclerosis 144 1999 185 198 (Pubitemid 29259980)
8. T.P. Bersot, G.L. Vega, and S.M. Grundy Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population J Lipid Res 40 1999 432-438
9. U. Hodoglugil, D.W. Williamson, and R.W. Mahley Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population J Lipid Res 51 2010 422 430
10. S.D. Abbasolu, H.P. Karpuzolu, B. Depboylu, N. Cine, M. Uysal, and G.A. Toker I450V and Taq IB polymorphisms of the cholesteryl ester transfer protein and their relation to serum lipid and lipoprotein levels in Turkish Population Cell Biochem Funct 27 2009 76 80
11. U. Hodolugil, D.W. Williamson, Y. Huang, and R.W. Mahley Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks Atherosclerosis 183 2005 199 212 (Pubitemid 41579269)
12. B.F. Asztalos, E.J. Schaefer, and K.V. Horvath Role of LCAT in HDL remodeling: investigation of LCAT deficiency states J Lipid Res 4 2007 592 599 (Pubitemid 46397462)
13. W.V. Brown, H.B. Brewer, D.J. Rader, and E.J. Schaefer HDL as a treatment target J Clin Lipidol 4 2010 5 16
14. D.J. Rader Lecithin:Cholesterol acyltransferase and atherosclerosis. Another high density lipoprotein story that doesn't quite follow the script Circulation 120 2009 549 552
15. G.K. Hovingh, B.A. Hutten, and A.G. Holleboom Compromised LCAT function is associated with increased atherosclerosis Circulation 112 2005 879 884 (Pubitemid 41170075)
16. A. Von Eckardstein Implications of torcetrapib failure for the future of HDL therapy: is HDL-cholesterol the right target Exp Rev Cardiovasc Ther 8 2010 345 358
17. Adult Treatment Panel III Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third report of The National Education Program (NECP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 28 2001 2486 2497
18. K. Zhang, S. Zhang, and K. Zheng Novel P143L polymorphism of the LCAT gene is associated with dyslipidemia in Chinese patients who have coronary atherosclerotic heart disease Biochem Biophys Res Commun 318 2004 4 10 (Pubitemid 38526238)
19. M. Manabe, T. Abe, M. Nozawa, A. Maki, M. Hirata, and H. Itakura New substrate for determination of serum lecithin:cholesterol acyltransferase J Lipid Res 28 1987 1206 1215 (Pubitemid 17151583)
20. K. Kobori, K. Saito, S. Ito, K. Kotani, M. Manabe, and T. Kanno A new enzyme-linked immunosorbent assay with two monoclonal antibodies to specific epitopes measures human lecithin-cholesterol acyltransferase J Lipid Res 43 2002 325 334 (Pubitemid 34184020)
21. K. Zhang, S. Zhang, Y. He, L. Zhang, Z. Su, Y. Sun, J. Shi, and Y. Tong Study on the association of Lecithin Cholesterol acyltransferase gene polymorphism with the lipid metabolism in coronary atherosclerotic heart disease Zhonghua Yi Xue Za Zhi 20 2003 135 137 (Pubitemid 36427805)
22. X.Y. Zhu, H.W. Xu, and R.Y. Hou Lecithin-cholesterol acyltransferase gene 608C/T polymorphism associated with atherosclerotic cerebral infarction Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23 2006 419 422
23. D. Recalde, A. Cenarro, F. Civeira, A.F. Garcia-Otin, and M. Pocovi A novel DNA polymorphism (4886C >T) in th human LCAT gene Hum Mut 15 2000 298-299
24. NCBI. Single nucleotide polymorphism. Available at: http://www.ncbi.nlm. nih.gov/SNP/snp-ref.cgi?locusId=3931. Accessed March 3, 2011.
25. A. Bauerfeind, H. Knoblauch, and M.C. Costanza Concordant association of lipid gene variation with a combined HDL/LDL-cholesterol phenotype in two European populations Hum Hered 61 2006 123 131 (Pubitemid 44385441)
26. S. Kathiresan, C.J. Willer, and G.M. Peloso Common variances at 30 loci contribute to polygenic dyslipidemia Nat Genet 41 2009 56 65
27. C.J. Willer, S. Sanna, and A.U. Jackson Newly identified loci that influence lipid concentrations and risk of coronary artery disease Nat Genet 40 2008 161 169 (Pubitemid 351171403)
28. V. Spirin, S. Schmidt, A. Pertsemlidis, R.S. Cooper, J.C. Cohen, and S.R. Sunyaev Common single-nucleotide polymorphisms act in concert to affect plasma levels of high- density lipoprotein cholesterol Am J Hum Genet 81 2007 1298 1303 (Pubitemid 350211459)
29. R. Movva, and D.J. Rader Laboratory assessment of HDL heterogeneity and function Clin Chem 54 2008 788 800 (Pubitemid 351671595)
30. B.A. Van Acker, G.J. Botma, A.H. Zwinderman REGRESS Study Group High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants Atherosclerosis 200 2008 161 167
31. J.T. Salonen, R. Salonen, K. Seppanen, R. Rauramaa, and J. Tuomilehto HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men Circulation 84 1991 129 139
32. N.E. Miller, J. Rajput-Williams, M.N. Nanjee, L. Samuel, and J.J. Albers Relationship of High density lipoprotein composition to plasma lecithin:cholesterol acyltransferase (LCAT) concentration in men Atherosclerosis 69 1988 123 129 (Pubitemid 18018603)
33. A.G. Holleboom, J.A. Kuivenhoven, and M. Vergeer Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: A prospective case-control analysis nested in the EPIC-Norfolk population study J Lipid Res 51 2010 416 421
34. B. Lamarche, S. Moorjani, B. Cantin, G.R. Dagenais, P.J. Lupien, and J.P. Despres Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study Arterioscler Thromb Vasc Biol 17 1997 1098 1105 (Pubitemid 27260329)
35. M.J. Stampfer, F.M. Sacks, S. Salvini, W.C. Willett, and C.H. Hennekens A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction N Engl J Med 325 1991 373 381